Rita Jain Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rita Jain.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rita Jain. Rita Jain is Director in ChemoCentryx, Inc. ($CCXI) and SVP, Chief Medical Officer in Akebia Therapeutics, Inc. ($AKBA) and Chief Medical Officer in Immunovant, Inc. ($IMVT).
Latest Insider Trading Transactions of Rita Jain
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, CCXI, IMVT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2021 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | M | 0.00 | 5,251 | 0 | 5,251 | |
Mar 30 2021 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Buy | M | 0.00 | 5,251 | 0 | 18,226 | 13 K to 18.2 K (+40.47 %) |
Mar 23 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Option Exercise | A | 17.00 | 342,300 | 5,819,100 | 342,300 | |
Mar 23 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Grant | A | 0.00 | 109,365 | 0 | 129,365 | 20 K to 129.4 K (+546.83 %) |
Jan 25 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Option Exercise | A | 42.19 | 220,000 | 9,281,800 | 220,000 | |
Jan 25 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | M | 0.00 | 5,251 | 0 | 10,502 | |
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Buy | M | 0.00 | 5,251 | 0 | 12,975 | 7.7 K to 13 K (+67.98 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Grant | A | 0.00 | 7,724 | 0 | 7,724 | 0 to 7.7 K |
Apr 12 2019 | AKBA | Akebia Therapeutic ... | Jain Rita | SVP, Chief Medical ... | Sell | D | 7.70 | 4,409 | 33,949 | 96,332 | 100.7 K to 96.3 K (-4.38 %) |
Mar 29 2019 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 0.00 | 15,753 | 0 | 15,753 | |
Dec 13 2018 | AKBA | Akebia Therapeutic ... | Jain Rita | SVP, Chief Medical ... | Payment of Exercise | F | 8.94 | 8,659 | 77,411 | 20,741 | 29.4 K to 20.7 K (-29.45 %) |
Jun 02 2017 | AKBA | Akebia Therapeutic ... | Jain Rita | SVP, Chief Medical ... | Option Exercise | A | 13.40 | 200,000 | 2,680,000 | 200,000 |
Page: 1